Successful treatment of late, recurrent wilms tumor with high-dose chemotherapy and autologous stem cell rescue in third complete response

Journal of Pediatric Hematology/oncology
Evangeline BrownMichelle Hudspeth

Abstract

Wilms tumor relapses are infrequent, occurring in approximately 15% of favorable histology patients. Very few cases of late recurrent relapse exist in the literature. Long-term survival after autologous stem cell rescue ranges from 40% to 73%, but there are very few reports of patients transplanted in their third complete response. We report a late recurrent relapse of Wilms tumor successfully treated with high-dose chemotherapy and autologous stem cell rescue in his third complete response who remains disease free 15 months posttransplant.

References

May 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P GrundyG J D'Angio
Jul 1, 1985·The Journal of Pediatrics·T H KimJ B Beckwith
Jan 1, 1994·Medical and Pediatric Oncology·S Gallego-MelcónJ Bellmunt
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F PeinO Hartmann
May 9, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A M Abu-GhoshM S Cairo
Dec 12, 2002·Bone Marrow Transplantation·B KremensN Graf
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew D CampbellMorris Kletzel
May 14, 2005·Journal of Pediatric Hematology/oncology·Paul J GibsonDonna L Johnston
Sep 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul E GrundyUNKNOWN National Wilms Tumor Study Group
Nov 30, 2005·The Oncologist·Monika L Metzger, Jeffrey S Dome
Feb 1, 2006·Pediatric Dermatology·Patsy LenaneBernice Krafchik
Jul 24, 2008·Bone Marrow Transplantation·S DallorsoUNKNOWN EBMT Paediatric Working Party

❮ Previous
Next ❯

Citations

Jun 6, 2013·Pediatric Blood & Cancer·M MalogolowkinUNKNOWN COG Renal Tumors Committee and the SIOP Renal Tumor Study Group
Dec 27, 2016·Korean journal of pediatrics·Akın AkakınTürker Kılıç
Apr 27, 2012·Korean journal of urology·So-Young LeeJae Y Ro
Apr 6, 2012·Current Opinion in Oncology·Kevin S Buckley
Apr 6, 2019·Journal of Pediatric Hematology/oncology·Woo Young ParkHee Young Shin
Apr 5, 2011·Current Opinion in Oncology·Kevin S Buckley
Feb 26, 2016·Journal of Pediatric Hematology/oncology·Hélène Sudour-BonnangeNathalie Rocourt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Pediatric Blood & Cancer
Faruk Güçlü PinarliCağlar Citak
Journal of Pediatric Hematology/oncology
Paul J GibsonDonna L Johnston
Medical and Pediatric Oncology
S Gallego-MelcónJ Bellmunt
© 2021 Meta ULC. All rights reserved